Shoshanna Fischhoff

In one of the world’s leading journals, The Lancet Neurology, Drs. Eva Feldman and Stephen Goutman join key international neurologists to publish recommendations based on new models of research, collaboration, and funding that could transform ALS into a livable condition for patients globally.

Eva L. Feldman, M.D., Ph.D., published a “Viewpoint” in JAMA Neurology that advocates for a new model to improve ALS research and care.

In a letter to the editor in Journal of the Peripheral Nervous System, a group led by Drs. Eva Feldman and Stephanie Eid makes a case for increased efforts in peripheral neuropathy research. Here are some of the issues they raise:

NIH support will allow Brian Callaghan, M.D., to study the medical and cost effectiveness of new Alzheimer’s medications in underrepresented communities.

The Washington Post interviewed Brian Callaghan, M.D., M.S., about recently published research about wait times for neurology appointments.

A review in one of the world’s top journals explores the impact of neuropathy and what steps need to be taken to alleviate its burden.

Dr. Stephen Goutman was installed as the inaugural recipient, thanks to the generosity of James Hiller and Linda Hiller Novak.

We look back at an incredible year by numbers and a timeline of key moments.

Lifestyle Intervention Research Covered by The Michigan Daily: "High-intensity exercise, calorie restriction reduces nerve damage in prediabetic mice, UMich study finds."

The research compared the effects of high-intensity interval training, caloric restriction, or their combination on improving metabolically acquired peripheral neuropathy (PN).

Researchers looked at medication cost trends for the five most common neurologic conditions.

Researchers compared two diagnostic tools used in neuropathy, one much less invasive, to understand which was more effective.

Researchers found that participants with ALS who had an older biological age compared to their chronological age had shorter survival; the findings were most pronounced in males and those in high-risk occupations.

The NeuroNetwork for Emerging Therapies welcomes a new postdoctoral fellow specializing in biostatistics.

The Osher Lifelong Learning Institute chose Eva L. Feldman, M.D., Ph.D., to be part of its Alfred Gourdji Distinguished Lectures Series.